Status: Recruiting
Stereotactic Magnetic Resonance Guided Radiation Therapy
This is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients with cancer. * The phase 1 study will evaluate the feasibility and safety of delivering SMART in patients with cancer. * Phase 2 will evaluate efficacy of SMART with specific reference to tumor control and improvement in patient reported outcome measures
Participants needed: 397
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: Nov 13, 2025Locations: 2
Eligibility criteria
Participants must have a confirmed malignancy requiring stereotactic body radiat... [+5]
Specific exclusion requirements for each disease site with be covered in each sp... [+4]